High-dose decanted triamcinolone for treatment-resistant persistent macular edema
Ophthalmic Surgery, Lasers and Imaging Sep 24, 2017
Muftuoglu IK, et al. - The consequence of decanted high-dose intravitreal triamcinolone acetonide (HD-IVTA) injection were demonstrated as a part of this research, for the treatment-resistant persistent macular edema (ME). The inference drawn was that a single HD-IVTA injection could yield a long duration of effect on ME of up to 6 months.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
